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Neointimal hyperplasia (NIH) and impaired dilatation are
important contributors to arteriovenous fistula (AVF) failure.
It is unclear whether chronic kidney disease (CKD) itself
causes adverse remodeling in arterialized veins. Here we
determined if CKD specifically triggers adverse effects on
vascular remodeling and assessed whether these changes
affect the function of AVFs. For this purpose, we used rats on
a normal diet or on an adenine-rich diet to induce CKD and
created a fistula between the right femoral artery and
vein. Fistula maturation was followed noninvasively by
high-resolution ultrasound (US), and groups of rats were
killed on 42 and 84 days after surgery for histological and
immunohistochemical analyses of the AVFs and contralateral
femoral vessels. In vivo US and ex vivo morphometric
analyses confirmed a significant increase in NIH in the AVFs
of both groups with CKD compared to those receiving a
normal diet. Furthermore, we found using histological
evaluation of the fistula veins in the rats with CKD that the
media shrank and their calcification increased significantly.
Afferent artery dilatation was significantly impaired in CKD
and the downstream fistula vein had delayed dilation after
surgery. These changes were accompanied by significantly
increased peak systolic velocity at the site of the anastomosis,
implying stenosis. Thus, CKD triggers adverse effects on
vascular remodeling in AVFs, all of which contribute to
anatomical and/or functional stenosis.
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Arteriovenous fistula (AVF) surgery is widely accepted as the
method of choice for dialysis access in patients with end-stage
renal disease.1 However, the 1-year patency rates of AVFs are
estimated to be only 63%,2 and recurrent AVF failure is a
major cause for morbidity and mortality of those patients.
The inability of the vein to dilate might cause maturation
failure in the early postoperative course.3 Moreover, neointi-
mal hyperplasia (NIH) may result in stenosis and, ultimately,
occlusion.4 Morphologically, NIH results from proliferation
of smooth muscle cells (SMCs) combined with matrix
deposition.
Chronic kidney disease (CKD) is associated with vascular
damage, and it is likely that uremia may impair AVF patency
too. Calcification of arteries due to media-sclerosis is a well-
known phenomenon in dialysis patients.5 Even though
vascular access calcification is also commonly observed in
hemodialysis patients,6 it is not known whether this may
affect fistula function.
Assessing how CKD specifically affects fistula failure
in humans is problematic, because AVF surgery is
almost exclusively performed in patients with end-stage
renal disease. In this context, small animal AVF models
have attracted great attention. The functional, structural,
and molecular responses in fistula veins following
arterialization have been recently described in mice7 and
rats.8–11 The majority of these experiments, however,
was performed in animals without CKD. In a very recent
study, it was demonstrated that CKD accelerates the
development of NIH due to increased vascular SMC
migration.12
However, phenotypical analysis of NIH cell composition
was not performed and it remained unclear whether these
specific changes affected fistula hemodynamics. Conse-
quently, the aim of the current study was to identify whether
CKD specifically triggers adverse effects on vascular remodel-
ing and to assess whether these changes are of functional
relevance.
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RESULTS
Surgical procedure
AVF surgery was successful in all rats (group no. 1¼ normal
diet, group no.2¼CKD) without any procedure-related
complications. The mean surgical time was 32min (range:
26–41). All animals survived the surgery, but two rats of
group no. 1 died between days 21 and 42 after surgery for
unknown reasons. The patency rate of the AVFs was 96% at
the time of harvesting. During the observation period, there
were no signs of peripheral ischemia resulting from steal or
edema caused by venous congestion.
Blood biochemistry and systolic blood pressure
As shown in Table 1, CKD was established 3 weeks after
feeding an adenine-rich diet to the rats of group no. 2. At the
time of surgery, serum creatinine values were 2.4 times those
of the baseline values. Subsequently, the creatinine values
remained significantly elevated throughout the study period.
Serum albumin and serum calcium were decreased by 23 and
1.5 % at the time of surgery and by 28 and 8% at the end of
the study period. Immediately before surgery, the serum
phosphate levels were increased by 25% and by 48% on day
42 after surgery. On day 84 after surgery, only a moderate
effect on the phosphate level was verifiable. The mean systolic
blood pressure was 116.2±11.2mmHg at baseline. After a
3-week feeding period, healthy animals of group no. 1 and
CKD rats of group no. 2 exhibited no significant difference in
systolic blood pressure (127.7±11.8mmHg vs 130.5±
18.5mmHg; P40.05).
Sono-morphological and functional characterization of
AVF maturation
The in vivo ultrasound (US) examinations confirmed
progressive NIH. Figure 1 shows a representative duplex-US
image of neighboring femoral artery and AVF as well as
respective B-Mode images containing pulse-waved Doppler
flow velocity tracings. The evolution of the NIH is depicted
in Figure 2a. Pronounced thickening of the neointimal
complex was observed in the fistula veins of all animals. The
neointima of group no. 1 animals showed a moderate
increase within the first 3 weeks after surgery (baseline:
0.033±0.006mm; day 21: 0.140±0.017mm, P¼ 0.001) and
a plateau thereafter until day 84 (0.150±0.032mm, P¼ 0.012
vs baseline value). In contrast, the CKD rats developed
progressively more neointimal thickening, which plateaued
only after day 63 (baseline: 0.087±0.029mm; day
–0.36
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Figure 1 |Ultrasound of the arterialized vein. Representative duplex-ultrasound image (a) of the femoral artery (FA) and the
arteriovenous fistula (AVF) in a rat of group no. 1 on day 84 after surgery. Shown on the right side is B-Mode images combined with Doppler
flow velocity tracings of the (b) afferent artery and (c) AVF. Horizontal marks on the scale bar represent the depth of ultrasound impression
(cm) and the velocities (cm/s).
Table 1 | Serum creatinine, serum calcium, serum phosphate
and serum albumin levels of rats fed with an adenine-rich
diet
Constituent
Feeding
period (days)
Adenine
diet
P-value
(difference
to baseline)
Creatinine, mmol/l 21 (baseline) 33.17±2.91
0 (surgery) 80.50±50.28 0.054
21 63.75±18.62 0.008
42 58.50±12.26 0.003
63 91.75±22.40 0.001
84 48.50± 5.85 0.001
Calcium, mmol/l 21 (baseline) 2.71±0.09
0 (surgery) 2.67±0.20 0.692
21 2.48±0.06 0.004
42 2.72±0.07 0.838
63 2.81±0.13 0.233
84 2.49±0.36 0.230
Phosphorous, mmol/l 21 (baseline) 1.71±0.46
0 (surgery) 2.27±0.75 0.167
21 1.52±0.26 0.530
42 2.91±0.25 0.003
63 1.71±0.19 0.913
84 1.75±0.48 0.021
Albumin, g/l 21 (baseline) 41.67±3.78
0 (surgery) 32.00±3.00 0.001
21 28.25±2.86 0.001
42 26.75±3.27 0.001
63 32.50±0.50 0.003
84 30.00±0.71 0.001
Values are mean±s.d.
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63: 0.340±0.030mm, P¼ 0.001 vs baseline value; day 84:
0.350±0.030mm, P¼ 0.002 vs day 84 group no. 1).
Parallel to NIH development, there were also changes
observed in the vessel diameter after AVF surgery in healthy
and uremic animals. In healthy animals (group no. 1), both
the afferent artery and AVF vein exhibited significant dilation
during the first 3 and 2 weeks, respectively. Thereafter, vessel
dilation remained constant at 176 and 220% of baseline
values, respectively. In CKD animals, this response was
impaired with veins only dilating to 142% of their original
size and femoral arteries exhibiting a significant contraction
to 80% of their original size (Figure 2b).
During fistula maturation, group no. 1 animals developed
an increase in peak systolic velocity (baseline: 8±4 cm/s,
day 84: 115±3 cm/s, P¼ 0.02), indicating a narrowing of the
anastomosis. This was significantly pronounced in CKD
animals (baseline: 3±1 cm/s, day 84: 876±171 cm/s, P¼
0.012 vs baseline, P¼ 0.008 vs control at day 84) (Figure 2c).
This increase in peak systolic velocity indicates that CKD
animals are more prone to develop an AVF stenosis than
controls.
Histomorphometric analysis of the neointima
For the histomorphometric analyses, hematoxylin and eosin-
stained serial sections were used (Figure 3a–h). At baseline
(control animals), the intima of femoral veins had a thickness
of one to two cell layers (7.02±2.16 mm). In contralateral
femoral veins (day 84) of group no. 1 and group no. 2, the
mean intima thickness was 6.61±0.52 and 6.62±0.53 mm,
respectively (Figure 4a). Thus, neither modified contralateral
hemodynamics nor chronic renal failure had an effect on
nonarterialized veins. Figure 4b describes the progression of
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Figure 2 | Effects during a 12-week period of maturation.
(a) Time course of neointimal thickening, (b) arterial and
arteriovenous fistula (AVF) diameters, and (c) peak systolic velocity
at the site of the anastomosis in chronic kidney disease (CKD) and
control animals. *Po0.05 vs respective day 0, #Po0.05 vs
respective time point in the control group. C, control;
CRF, chronic renal failure.
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Figure 3 |Histological 2lm cross sections stained with
hematoxylin and eosin ( 100) of the arteriovenous fistula
(AVF) anastomosis (level L3) and its respective contralateral
vessels (femoral artery and vein). AVF on day 42 (a) and day 84
(b) in the chronic kidney disease (CKD) group. Note the extensive
neointimal thickening (black arrow) in the fistula vein. White
arrow shows surgical thread material. Significantly less neointimal
hyperplasia in rats receiving normal diet (c, d). Intima and media
of contralateral control vessels are not affected by the adenine
diet (e, f) and have the same morphology as controls receiving
normal diet (g, h). A, artery; V, vein.
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NIH after surgery in this model, based on morphometrical
analysis. On days 42 and 84 after surgery, a marked
neointimal thickening was observed in group no. 2, whereas
in group no. 1 only a slight increase in neointima thickness
developed as a consequence of the arterialized inflow. For
both time points, this increase in NIH was significant
(Po0.014). The changes in the media developed inversely,
displayed by the media shrinking significantly in the CKD
group, when compared with group no. 1 (Po0.02). Thus,
intima/media thickness ratios showed a significant difference
between both groups at both time points, too (Po0.0002)
(Figure 4c). This indicates that maturation of arterialized
veins in CKD was associated with a distinct growth of a
neointimal complex accompanied with a diminution of the
media. The thickness of the adventitial layer was nearly
unaffected by the different diets throughout the study period.
Immunohistochemical staining
To characterize the cell composition within the neointima
and the media, sections from level L3 were assessed, which
represents the proximal side of the AVF anastomosis.
Figure 5a–d describes the semiquantitative scores on days
42 and 84 after surgery. The majority of cells in both groups
within the neointima were myofibroblasts. The images of
Figure 5e–g show representative histological sections with
NIH, demonstrating the abundance of myofibroblasts and
the presence of SMCs. The data in Table 2 demonstrate that
apoptosis and proliferation rates were significantly increased
in group no. 2.
The dominant cell type within the media of the AVF in
renal failure rats on days 42 and 84 after surgery was the
myofibroblast too. On day 42, the media of group no. 1 rats
showed significantly less vimentin-positive (Po0.04) and
significantly more desmin-positive cells (Po0.006), indicat-
ing a higher amount of SMCs. On day 84, however, no
significant difference in cellular phenotyping between both
groups was revealed. Although the apoptosis rate showed no
significant differences for both groups, the proliferation rate
was significantly increased in the chronic renal failure group
(Table 2).
Determination of AVF calcification
Analysis of von Kossa staining serial sections revealed
significant calcification in animals of group no. 2
(Figure 6a and b; Po0.0001) when compared with group
no. 1 (Figure 6c and d) and contralateral controls
(Figure 6e–h). In healthy animals, just marginal calcification
was observed at both the thread site and vein valves site. After
42 postoperative days, the arterial calcification in CKD
animals was mostly located in the media of the afferent
artery, suggesting a development of mediasclerosis. However,
84 days after surgery, calcification was found in both the
intima and media layer. Here, a marked calcification of
the fistula vein was also observed (Figure 6i). In particular,
83.3% of the intima and 61.1% of the media sections at levels
L3–L6 representing the downstream vein, stained positive for
calcification.
DISCUSSION
This is, to our knowledge, the first study that combines a
detailed analysis of the structural changes in arterialized veins
with a functional evaluation by means of noninvasive US
imaging in small animals with CKD.
Our first major finding is that animals with CKD
developed extensive NIH combined with a shrinking of the
media layer, whereas healthy animals had only moderate
neointimal formation as a response to the arterialized inflow.
The second major finding is the severe calcification in fistula
veins of CKD rats. Finally, the feeding artery and the fistula
vein exhibit an inferior dilation after arterialization. Alto-
gether, these adverse effects resulted in anastomotic stenoses
with concomitant alterations of AVF hemodynamics.
Previous small animal studies were very useful in
examining different pathomechanisms to analyze AVF fail-
ure.7–11,13,14 None of these studies, however, had accurately
depicted the clinical situation of patients with end-stage renal
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Figure 4 | Time course effect of chronic kidney disease (CKD)
on neointimal thickening in the arteriovenous fistula (AVF).
(a) Intima and media thickness of control femoral veins based on
morphometry (average of level L1–L6). To exclude an effect of the
diet and of contralateral hemodynamics, three different controls
were performed: On day 84, femoral veins of rats without surgery
(black bar), contralateral femoral veins of group no. 1 (white bar)
and contralateral femoral veins of group no. 2 (shaded bar)
animals had the same thickness, suggesting that neither the
adenine diet nor the contralateral hemodynamics had systemic
effects on neointimal development. (b) The intima increased
significantly in chronic renal failure, days 42 and 84 after surgery.
At the same time, the media decreased significantly.
Consequently the intima/media ratio (c) showed a significant
difference at day 42 and 84. *Po0.05 vs respective day 0, #Po0.05
vs respective time point in group no. 2.
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disease, in which uremia may contribute to adverse vascular
remodeling effects. To compensate for this, we successfully
upgraded our previously described femoral AVF model9
using rats with CKD induced by adenine.
There are several inherent advantages of our CKD model.
Adenine-induced nephropathy is a well-established experi-
mental model for the rat that strongly resembles the natural
course of CKD in humans. This model is characterized by a
gradual loss of renal function and presents many clinical
features, which are associated with a chronic progressive renal
failure.15 It has been shown that the degree of uremia varies
with dosage and length of the adenine administration and
that the degree of uremia correlates with mortality. There-
fore, we could induce a well-defined degree of CKD (serum
levels of creatinine ranging from 48.5 to 80.5mmol/l) that
also allowed us to perform AVF surgery in these sick animals
with acceptable mortality rates (o10%).
In contrast, a survival rate of only 33% is reported for the
remnant kidney model 6 weeks after the surgical procedure.16
This high mortality rate strongly limits the possibility of a
longitudinal AVF maturation analysis, especially when the
observation period has to be extended 46 weeks post-
operatively. Furthermore, rats with remnant kidney are prone
to develop hypertension, which may cause adverse hemody-
namic effects.17,18
In our protocol, we have excluded a possible effect of
systemic hypertension in CKD rats. Moreover, a direct effect
of adenine on the vasculature was not detectable in
contralateral femoral vessels. Therefore, we presumed that
it was the uremic environment rather than indirect effects
that caused the exacerbation of NIH and calcification within
the AVFs. Our results confirmed that CKD induction using
the adenine-enriched diet resulted in abnormal electrolyte
metabolism, in particular, hypocalcemia and hyperphos-
phatemia and, furthermore, hypoalbuminemia and elevated
serum creatinine values. This is in accordance with Yokozawa
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Figure 5 | Intensity scoring and cellular phenotyping in healthy and chronic kidney disease (CKD) rats. The cellular phenotype
intensity score (positive cells for each of the specific marker as a percentage of the total number of cells; 0–10%¼ 0, 11–25%¼ 1,
26–50%¼ 2, 51–75%¼ 3, and 76–100%¼ 4) for the neointima (a and b) shows no difference in the cell composition within the intima
between both groups. The intensity score for the media demonstrates significantly less vimentin-positive and significantly more desmin-
positive cells in healthy animals on day 42 (c). In contrast, most of the cells within the shrunk media of CKD animals are myofibroblasts. On
day 84, the media is primarily based on myofibroblasts in both groups (d). (e, f) Representative serial sections with extensive neointimal
formation from level L3 stained for smooth muscle actin (SMA) (e), vimentin (f), and desmin (g). The predominant neointimal cell type is the
SMA-positive and vimentin-positive myofibroblast (black lined ellipse). The red dotted ellipse shows an SMA-positive and desmin-positive
contractile smooth muscle cell.
Table 2 | Histomorphometric analysis of apoptosis and
proliferation within the intima and media on days 42 and 84
after surgery
Postoperative
day
Apoptosis
(Tunel), %
Proliferation
(PCN1), %
A/P
ratio
Intima
Group no. 1 42 28±10 32±10 0.88
84 21±17 29±11 0.72
Group no. 2 (CKD) 42 49±17* 49±6* 1.00
84 42±16* 40±18* 1.05
Media
Group no. 1 42 27±16 12±13 2.25
84 41±21 7±7 5.85
Group no. 2 (CKD) 42 38±12 31±11* 1.23
84 28±17 15±9* 1.87
Abbreviations: A/P ratio, apoptosis/proliferation ratio; CKD, chronic kidney disease.
*Po0.05 vs respective group no. 1.
The values represent the percentage of positive cells for each of the specific markers
as a percentage of the total number of cells. Rats of group no. 2 had a significant
increased apoptosis and proliferation rate within the neointimal hyperplasia when
compared with group no. 1. Regarding the media, more cells stained positive for
apoptosis than proliferation in both groups; however, this effect was more
distinguished in group no. 1.
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et al.15 and Katsumata et al.,19 who proved close resemblance
to metabolic abnormalities in human chronic renal failure.
Aggravation of NIH in animals with CKD
The NIH development in fistula veins is considered to be a
multifactorial event.3 There is increasing evidence that
surgical trauma and modified hemodynamics are associated
with endothelial and SMC damage.20 In a few small7,8,10,11
and large21–25 animal studies, NIH formation could be
repeatedly observed after AVF surgery and it has been shown
that CKD accelerates NIH development.12 To assess whether
CKD resulted in specific morphological and functional
changes, we have investigated AVFs noninvasively by means
of US, and, combined these findings with histopathological
analyses. In both experimental groups, we observed a
development of NIH. Importantly, we show that the
development of NIH was much more pronounced in CKD
animals. In accordance with that observation, we found
increased apoptosis- and proliferation-rates within the
neointima, indicating an increased cell-turnover. This
strongly suggests that metabolic abnormalities in CKD
trigger adverse neointimal thickening in a short-term period
after surgery. This, in fact, confirms the recent findings of
Kokubo et al.,12 who described an accelerated development of
NIH within 3 weeks after surgery at the site of the
anastomosis (jugular vein to carotid artery) in an experi-
mental mouse model in animals with CKD. Extending these
findings, we have determined that NIH developed not only
within the anastomosis yet more downstream in the fistula
vein, too. Moreover, we show that NIH development
remained constant 21 days after surgery in healthy animals,
but still continued in CKD animals until day 84 after AVF
placement. A further novel observation is that, parallel to the
NIH development, a significant shrinking of the media
occurred in CKD rats. Because the proliferation rate within
the media in these animals was significantly increased, we
assume that the media substance loss in CKD was caused by
an increased inward migration of SMC and myofibroblasts,
which in turn confirms previous findings in patients.26
CKD causes neointimal and media calcification of
fistula veins
It is well known that uremia-associated risk factors such as
chronic inflammation and deficiencies of calcification
inhibitors contribute to progressive vascular calcification in
patients with end-stage renal disease.27 The process does not
merely consist in passive deposition of calcium phosphate
crystals; it is clear that it is a well-organized process involving
cell activity and specific protein synthesis.28 Previous research
concerning this matter focused exclusively on calcifying
atherosclerosis of arteries,5 and the role of calcification in
veins has been marginally investigated so far.6 In this study,
we found marginal calcification in healthy animals at the site
of the vein valves, which is in accordance to previous
observations.9 Nonetheless, the major novel finding is the
significant calcification at all histological levels in animals
with uremic background. Furthermore, this was accompa-
nied with increased apoptosis levels within the neointima
layer. Data from previous studies support a causal relation-
ship between apoptotis and calcification.29,30 Thus, our
results suggest that calcification in fistula veins is aggravated
by a CKD-induced SMC apoptosis.
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Figure 6 | Time course effect of chronic kidney disease (CKD)
on vessel wall calcification in the fistula vein. An extensive
calcification (black arrows) of the neointima and media were
observed in CKD on days 42 (a) and 84 (b) after surgery. In
contrast, the incidence of calcification in the downstream vein
of group no. 1 was below 10% of the sections (c and d).
No calcification occurred in control veins (e–h). The frequency of
vein calcification was significantly increased in the CKD group (i),
when compared with normal diet rats (*Po0.05 vs respective
group no. 1).
Kidney International (2010) 78, 1312–1321 1317
S Langer et al.: CKD aggravates AVF damage o r ig ina l a r t i c l e
It has been recently shown that arterial vessel calcification
in dialysis patients was associated with a large extent of
undercarboxylated matrix-Gla protein expression, which
indicates an exhaustion of local calcification inhibition
capability.31 In contrast to the typical media-sclerosis in
arteries, we have found both a rapid development of
neointimal and media calcification located at the site of the
anastomosis and within the wall of the fistula vein. This
suggests that the surgical trauma and the foreign suture
material may influence the deposition of the calcium.
However, we can exclude this effect in the downstream
fistula vein, in which the calcification was almost the same.
Taken together, an important impairment of local calcifica-
tion inhibitors in CKD can be assumed and further
investigation is essential.
Impaired AVF maturation
In patients, vein dilation after arterialization is a part of a
physiological AVF maturation process, which makes recur-
rent cannulation for dialysis possible. In general, a change of
hemodynamic parameters—increase of blood pressure, flow
volume, and wall shear stress—causes a physiological dilation
in the downstream vein. This response returns shear-stress
levels back toward their baseline.3 In the setting of early AVF
failure, the role of insufficient dilation is unclear, but it is well
known that fistula vein dilatation occurs rapidly after AVF
creation.32,33 Accordingly, we have observed an B220%
increase in fistula vein diameter in healthy animals within 6
weeks, whereby this dilation remained stable thereafter. In
contrast, CKD was associated with an impairment of fistula
vein dilation after surgery. Moreover, the afferent artery is
also adversely affected. This implies that CKD adversely
affects the ability of the vessels to dilate, which is
consequently an adverse effect for the maturation process.
Our data strongly suggest that the impaired dilation of fistula
veins in CKD is a result of the extended calcification as well
as the significant increase of myofibroblasts, which represent
the major source for extracellular collagen deposition within
the vein wall. It has also been reported that the predominant
cell type within NIH formation is the myofibroblast in
patients with end-stage renal disease.34 Thus, our rat model
offers an excellent experimental setting to test future novel
therapies that will target myofibroblast function.
Development of AVF stenosis
In our study, aggravation of neointimal thickening, progres-
sive access calcification, and impaired dilation all lead to
increased flow velocities in the US investigations that indicate
a reduction of luminal area and, ultimately, a development of
AVF stenosis. In an experimental porcine AVF model, Misra
et al.22 showed increased shear-stress levels at the site of vein-
to-graft anastomosis on days 1, 3, and 7 after surgery. We
assume that CKD may potentiate those adverse biomecha-
nical forces at the site of high-flow velocity regions in fistula
veins; this, in turn, is a vicious cycle that aggravates NIH
development.
Our data illustrate that CKD itself triggers adverse effects
in AVFs. This leads to impaired vascular remodeling
contributing to AVF stenosis. Consequently, AVF surgery in
adenine-induced renal failure rats provides the research
community a reliable model that can be used to test novel
therapeutic strategies to improve AVF maturation and
patency in hemodialysis patients.
MATERIALS AND METHODS
Female 12-week-old Sprague–Dawley rats (270–330 g) were
purchased from a commercial breeder (Charles River Wiga
GmbH, Sulzfeld, Germany). They were kept in a climate-
controlled room (21 1C and 60% relative humidity) with a
12-h cycle of light and darkness and were housed in normal
cages with free access to water and food. All experiments were
approved by the local animal human board and were
performed in accordance with the legislation on the
protection of animals (AZ 50.203.2-AC 26, 54/06).
Adenine diet-induced CKD
It has been shown that a long-term feeding of adenine to rats
produces metabolic abnormalities resembling chronic renal
failure in humans.15,35 This feeding of adenine to rats results
in interstitial nephritis, in particular in the deposition of 2,8-
dihydroxyadenine in the renal tubules, which subsequently
induces a degeneration, interstitial fibrosis, and atrophy of
the proximal and distal tubules,19 leading to the accumula-
tion of various guanidine compounds and urea nitrogen in
the blood.
Experimental groups
A total of 28 animals was used for this study. Twenty-four
rats were separated into two groups (n¼ 12 rats/group); four
animals served as healthy controls. The rats of group no. 1
along with the four healthy controls received commercial
feed, whereas the animals of group no. 2 received an adenine-
rich diet (0.75% adenine, ssniff Spezialdia¨ten GmbH, Soest,
Germany) preoperatively for 3 weeks to induce CKD. The
level of renal insufficiency was controlled using serum creati-
nine values. When CKD was established in group no. 2, both
groups underwent AVF surgery. Due to decreasing serum
creatinine levels 6 weeks postoperatively, the animals of
group no. 2 were again fed with adenine-enriched diet for
1 week. The AVF rats of both groups were postoperatively
examined with high-resolution US on days 1, 7, 14, 21, 42,
63, and 84. As shown in Figure 7, half of the animals of each
group was killed and their tissues were harvested on days 42
and 84, respectively.
Microsurgical procedure
Animals underwent AVF surgery on the right femoral artery
as previously described.9 Briefly, the femoral vein was
anastomosed to the femoral artery in an end-to-side manner
using a 10–0 monofilament (Serapren, Serag-Wiessner, Naila,
Germany) running suture. A dilation of the arterialized vein
could be observed shortly after clamp removal (Figure 8a).
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High-resolution US
The afferent femoral artery, anastomosis, and fistula vein
were visualized with a 12-MHz transducer (GE Vivid pro 7,
GE Medical Systems, Solingen, Germany). After the char-
acteristic blood flow pattern of the vessel was identified, the
position of the probe was optimized to show clear vessel
wall/lumen interfaces and longitudinal B-Mode images.
Moreover, Doppler signals were recorded. Vessel diameters
and neointimal thickness were measured by automated
analysis software (Brachial Analyzer, Medical Imaging
Applications, Iowa City, IO, USA).
Measurement of systolic blood pressure
Systolic blood pressure was measured using the tail-cuff
method (Softron BP-98A, Softron; Tokio, Japan). Rats were
put in a restriction cage that was placed in a 37 1C heated
tube for 15min. The cuff that occluded the flow of blood into
the tail was inflated to a maximum of 200mmHg and
deflated automatically at a rate of 10mmHg/s. Animals were
habituated to the procedure by 10 cycles of inflation and
deflation. Thereafter, six measurements were performed with
each animal, and mean values were calculated.
Harvesting, specimen preparation, and terminology
Tissue harvesting was performed as previously described.9
The entire AVF was removed en bloc and placed in formaline,
embedded in paraffin, and serially sectioned in 2 mm sections.
The AVF anastomosis and downstream fistula vein were
longitudinally divided into six parts as depicted in Figure 8b.
Histological sections from each proceeded for evaluation.
Histological and immunohistochemical analysis
Sections from each level were stained with hematoxylin and
eosin, elastica van Gieson, and von Kossa. Immunohistology
was performed using commercial antibodies (Table 3).
Standard immunohistochemistry protocols were followed;
deparafinization and hydration was followed by antigen
demasking (2% cintate buffer in a microwave) and
nonspecific protein binding with 1% fetal calf serum in Tris
buffer for 10min, Avidin D solution for 10min and Biotin
solution for 10min (Vector Kit SP 2001, Vector Laboratories,
Burlingame, UK). Primary antibody incubation took place
Group 1
Group 2 Adenin Adenin
Day
Surgery
US
blood
US US US
blood
US
blood
sacrifice
US
blood
US
blood
sacrifice
–21 –14 –7 0 7 14 21 28 35 42 49 56 63 70 77 84
Figure 7 | The study design shows a total study period of 15 weeks. Of these, 3 weeks were the preoperative time, when rats of the
chronic kidney disease group (group 2) received an adenine-rich diet. Because of decreasing serum creatinine values after 42 postoperative
days, animals of group 2 again received an adenine-rich diet for 1 week. On day 0, rats underwent arteriovenous fistula (AVF) surgery.
Ultrasound investigations were performed periodically during the 12 postoperative weeks. Rats were killed on days 42 (week 6) and 84
(week 12) after surgery.
FA
AVF
40 µm
L1 L2 L3 L4 L5 L6
Ana
Figure 8 |AVF of the end of the surgical procedure after clamp
removal. (a) Intraoperative image (25-fold magnification).
The running suture shows the site of the end-to-side anastomosis
(Ana) between the femoral artery (FA) and femoral vein, resulting
in an arteriovenous fistula (AVF). (b) Schematic illustration of the
histological section levels (L1–L6). L1 is at the distal side of the
anastomosis; L2 is at the middle part where the diameter of both
participating artery and vein are of equal size; L3 is at the proximal
side of the anastomosis. The next three levels are lined every
40mm, meaning every 20 serial sections of 2 mm thickness
(L4, L5, and L6, respectively).
Table 3 | List of antibodies and negative controls that were
used for the immunohistological staining
Antibody Negative control
Company Dilution Company
a-Smooth muscle actin DAKO M0851 1:300 IgG2a DAKO X0943
Vimentin DAKO M0725 1:100 IgG1 DAKO X0931
Desmin DAKO M0760 1:100 IgG1 DAKO X0931
PCNA DAKO M0879 1:400 IgG2a DAKO X0943
Abbreviations: IgG, immunoglobulin G; PCNA, proliferating-cell nuclear antigen.
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overnight at 4 1C and a secondary antibody blend incubation
followed for 10min at room temperature, followed with
streptavidin/horseradish peroxidase incubation for 10min
(DAKO-Kit LSAB2 System-HRP K0673, DAKO, Hamburg,
Germany). Substrate solution was applied for development
(NovaRED, Vector SK-4800, Vector Laboratories) and
counterstaining with hematoxylin.
A TdT-mediated dUTP nick end labeling reaction was
performed according to the manufacturer’s instructions
(In situ Cell Death detection kit, POD, Roche 11684817910,
Roche Diagnostics GmbH/Roche Applied Science, Man-
nheim, Germany) for the assessment of apoptosis in serial
sections to the ones stained with proliferating-cell nuclear
antigen for proliferation.
Histomorphometric analysis and identification of
cellular phenotypes
Two sections from each level (L1 to L6, Figure 2b) were
sampled in order to measure their respective intima-, media-,
and adventitia thickness. Twenty equidistant radial measure-
ments were conducted for each layer, and the values
were averaged. Histographs from hematoxylin and eosin-
and elastica van Gieson-stained sections were taken at a final
magnification of  40 using a Nikon Eclipse 80i micro-
scope, a Nikon Digital sight DS-2Mv camera (Nikon GmbH,
Duesseldorf, Germany) and a Windows work station. Nikon
NIS-Elements D 3.0 software was used for morphometric
analyses.
To evaluate calcification, sections from every level were
stained with von Kossa stain. These stains were scored as
positive or negative depending on whether calcium crystals were
observed or not. For each level, the presence of theses crystals
was scored and the location documented (Vessel, layer, suture).
Different combinations of immunohistological stains on
serial sections were used to differentiate between
K contractile medial-like SMCs (smooth muscle actin
(SMA) positive, vimentin negative, desmin positive),
K myofibroblasts (smooth muscle actin positive, vimentin
positive, desmin negative) and
K fibroblasts (smooth muscle actin negative, vimentin
positive, desmin negative).
K As previously introduced by Chaudhury et al.,34 a
semiquantitative intensity scoring scale from 0 to 4 was
used to quantify the percentage of positive cells for the
specific markers.
Blood biochemistry
Serum phosphorous, serum calcium, and serum creatinine
levels were determined using an autoanalyzer (Vitros 250,
Ortho-Clinical Diagnostics, Strassbourg, France).
Statistics
Continuous data were reported as arithmetic mean±s.d.;
categorical data were expressed as frequencies and percentage.
The primary test for an effect inferred from US-generated data
was a test of the interaction in a one-way repeated measures
analysis of variance. The family of pairwise comparisons was
conducted using the Holm-Sidak method.
The histomorphometric data were analyzed using a
repeated measures analysis of variance model taking
into account the multiple measurements per animal from
different intersectional planes. The median of the 20
measurements per layer was used in order to reduce
variability in the data due to artefacts. Calcification
frequencies were compared using Fisher’s exact test.
P-Values o0.05 were considered as significant. All
analyses were performed with SigmaStat 3.5 (Systat Software,
San Jose, CA, USA) or SAS 9.1 (Copyright & 2002–2003 by
SAS Institute, Cary, NC, USA.).
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